Heterocyclic carbonyl compounds
88 Citations•2005•
ディーター ドルシュ, ロルフ ゲリッケ, ヴェルナー メデルスキー
journal unavailable
New heterocyclic compounds of the formula (I) (wherein, R 1, D, W, T, and T has the meanings indicated in claim 1) is a SGK inhibitors, SGK may be used for the treatment of induced diseases and conditions.
Abstract
New heterocyclic compounds of the formula (I) (wherein, R 1, D, W, T, and T 'has the meanings indicated in claim 1) is a SGK inhibitors, SGK may be used for the treatment of induced diseases and conditions. And Such diseases and conditions, diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary muscle hypertonia, cardiovascular diseases and renal disease, etc. Generally any type of fibroses and inflammatory processes .